SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549 

                         ------------------------------

                                    FORM 8-K


                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(D) OF THE

                         SECURITIES EXCHANGE ACT OF 1934


       Date of Report (Date of earliest event reported): DECEMBER 31, 1997

                           OPHTHALMIC IMAGING SYSTEMS
             ------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)
             

         CALIFORNIA                   1-11140                  94-3035367
- ----------------------------   -----------------------        ------------
(State or Other Jurisdiction   (Commission File Number)      (IRS Employer
        Incorporation)            Identification                Number)


         221 LATHROP DRIVE, SUITE I, SACRAMENTO, CALIFORNIA       95815
         --------------------------------------------------     ---------
             (Address of Principal Executive Offices)           (Zip Code)


      Registrant's telephone number, including area code:  (916) 646-2020


                                   Page 1 of 6




ITEM 5.  OTHER EVENTS.

      On December 31, 1997, the Board of Directors of Ophthalmic Imaging Systems
(the "Company") declared a dividend of one preferred share purchase right (a
"Right") for each outstanding share of common stock, no par value per share (the
"Common Shares") payable on January 2, 1998 (the "Record Date") to the
shareholders of record on that date. Each Right entitles the registered holder
to purchase from the Company one one one-hundredth of a share of Series A Junior
Participating Preferred Stock, no par value per share ("Preferred Shares") of
the Company at a price of $10.00 per one one-hundredth of a Preferred Share (the
"Purchase Price"), subject to adjustment. The description and terms of the
Rights are set forth in a Rights Agreement (the "Rights Agreement") between the
Company and American Securities Transfer, Inc., as Rights Agent (the "Rights
Agent").

      Until the earlier to occur of (i) 10 days following a public announcement
that a person or group of affiliated or associated persons (an "Acquiring
Person") shall have acquired beneficial ownership of 20% or more of the
outstanding Common Shares, or (ii) 10 business days (or such later date as may
be determined by action of the Board of Directors prior to such time as any
person or group of affiliated persons becomes an Acquiring Person) following the
commencement of, or announcement of an intention to make, a tender offer or
exchange offer the consummation of which would result in the beneficial
ownership by a person or group of 20% or more of such outstanding Common Shares
(or, in the case of a tender or exchange offer commenced by Premier Laser
Systems, Inc. ("Premier Laser"), a tender or exchange offer the consummation of
which would result in Premier Laser becoming the beneficial owner of an
additional 1% of the Common Shares then-outstanding than are beneficially owned
by Premier Laser as of the close of business on December 31, 1997 (the
"Effective Date")) (the earlier of such dates being a "Distribution Date"), the
Rights will be evidenced, with respect to any of the Common Share certificates
outstanding as of the Record Date, by such Common Share certificate with a copy
of the Summary of Rights (a form of which is included as Exhibit C to the Rights
Agreement) attached thereto. An "Acquiring Person" will not be deemed to include
Premier Laser which has filed a Schedule 13D under the Securities Exchange Act
of 1934, as amended, unless Premier Laser becomes the beneficial owner of an
additional 1% or more of the Common Shares then-outstanding than Premier owned
at the close of business on the Effective Date.

      The Rights Agreement provides that, until the Distribution Date (or
earlier redemption or expiration of the Rights), the Rights will be transferred
with and only with the Common Shares. Until the Distribution Date (or earlier
redemption or expiration of the Rights), new Common Share certificates issued
after the Record Date upon transfer or new issuance of Common Shares will
contain a notation incorporating the Rights Agreement by reference. Until the
Distribution Date (or earlier redemption or expiration of the Rights), the
surrender for transfer of any certificates for Common Shares outstanding as of
the Record Date, even without such notation or a copy of the Summary of Rights
being attached thereto, will also constitute the transfer of the Rights
associated with the Common Shares represented by such certificate. As soon as
practicable following the Distribution Date, separate certificates evidencing
the Rights ("Right Certificates") will be mailed to holders of record of the
Common Shares as of the close of business on the Distribution Date and such
separate Right Certificates alone will evidence the Rights.

      The Rights are not exercisable until the Distribution Date. The Rights
will expire on December 31, 2007 (the "Final Expiration Date"), unless the Final
Expiration Date is extended or unless the Rights are earlier redeemed by the
Company, in each case, as described below.


                                  Page 2 of 6




      The Purchase Price payable, and the number of Preferred Shares or other
securities or property issuable, upon exercise of the Rights are subject to
adjustment from time to time to prevent dilution (i) in the event of a stock
dividend on, or a subdivision, combination or reclassification of, the Preferred
Shares, (ii) upon the grant to holders of the Preferred Shares of certain rights
or warrants to subscribe for or purchase Preferred Shares at a price, or
securities convertible into Preferred Shares with a conversion price, less than
the then-current market price of the Preferred Shares or (iii) upon the
distribution to holders of the Preferred Shares of evidences of indebtedness or
assets (excluding regular periodic cash dividends paid out of earnings or
retained earnings or dividends payable in Common Shares) or of subscription
rights or warrants (other than those referred to above).

      The number of outstanding Rights and the number of one one-hundredths of a
Preferred Share issuable upon exercise of each Right are also subject to
adjustment in the event of a stock split of the Common Shares or a stock
dividend on the Common Shares payable in Common Shares or subdivisions,
consolidations, or combinations of the Common Shares occurring, in any such
case, prior to the Distribution Date.

      Preferred Shares purchasable upon exercise of the Rights will not be
redeemable. Each Preferred Share will be entitled to a minimum preferential
quarterly dividend payment of $1.00 per share but will be entitled to an
aggregate dividend of 100 times the dividend declared per Common Share. In the
event of liquidation, the holders of the Preferred Shares will be entitled to a
minimum preferential liquidation payment of $100 per share but will be entitled
to an aggregate payment of 100 times the payment made per Common Share. Each
Preferred Share will have 100 votes, voting together with the Common Shares.
Finally, in the event of any merger, consolidation, or other transaction in
which Common Shares are exchanged, each Preferred Share will be entitled to
receive 100 times the amount received per Common Share. These rights are
protected by customary anti-dilution provisions.

      Because of the nature of the Preferred Shares' dividend, liquidation, and
voting rights, the value of the one one-hundredth interest in a Preferred Share
purchasable upon exercise of each Right should approximate the Board of
Director's estimated value of one Common Share.

      In the event that the Company is acquired in a merger or other business
combination transaction or 50% or more of its consolidated assets or earning
power are sold after a person or group has become an Acquiring Person, proper
provision will be made so that each holder of a Right will thereafter have the
right to receive, upon the exercise thereof at the then current exercise price
of the Right, that number of shares of common stock of the acquiring company
which at the time of such transaction will have a market value of two times the
exercise price of the Right. In the event that any person or group of affiliated
or associated persons becomes an Acquiring Person, proper provision shall be
made so that each holder of a Right, other than Rights beneficially owned by the
Acquiring Person (which will thereafter be void), will thereafter have the right
to receive upon exercise that number of Common Shares having a market value of
two times the exercise price of the Right.

      At any time after a person or group of affiliated or associated persons
becomes an Acquiring Person and prior to the acquisition by such person or group
of 50% or more of the outstanding Common Shares, the Board of Directors of the
Company may exchange the Rights (other than Rights owned by such person or group
which have become void), in whole or in part, at an exchange ratio of one Common
Share, or one one-hundredth of a Preferred Share (or of a share of a class or
series of the Company's preferred stock having equivalent rights, preferences,
and privileges), per Right (subject to adjustment).


                                  Page 3 of 6




      With certain exceptions, no adjustment in the Purchase Price will be
required until cumulative adjustments require an adjustment of at least 1% in
such Purchase Price. No fractional Preferred Shares will be issued (other than
fractions which are integral multiples of one one-hundredth of a Preferred
Share, which may, at the election of the Company, be evidenced by depository
receipts) and in lieu thereof, an adjustment in cash will be made based on the
market price of the Preferred Shares on the last trading day prior to the date
of exercise.

      At any time prior to a person or group of affiliated or associated persons
becoming an Acquiring Person, the Board of Directors of the Company may redeem
the Rights in whole, but not in part, at a price of $.01 per Right (the
"Redemption Price"). The redemption of the rights may be made effective at such
time on such basis and with such conditions as the Board of Directors in its
sole discretion may establish. Immediately upon any redemption of the Rights,
the right to exercise the Rights will terminate and the only right of the
holders of Rights will be to receive the Redemption Price.

      The terms of the Rights may be amended by the Board of Directors of the
Company without the consent of the holders of the Rights, except that from and
after such time as any person becomes an Acquiring Person no such amendment may
adversely affect the interests of the holders of the Rights.

      Until a Right is exercised, the holder thereof, as such will have no
rights as a shareholder of the Company, including without limitation, the right
to vote or to receive dividends.

      The foregoing summary description of the Rights and the Rights Agreement
does not purport to be complete and is qualified in its entirety by reference to
the Rights Agreement, a copy of which has been filed as an exhibit to this Form
8-K, and is hereby incorporated herein by reference thereto.

ITEM 7.  EXHIBITS.

EXHIBIT NO.    DESCRIPTION
- -----------    -----------

     1 -       Rights Agreement, dated as of December 31, 1997, between
               Ophthalmic Imaging Systems and American Securities Transfer,
               Inc., including form of Rights Certificate attached thereto.

     2 -       Press Release dated December 31, 1997 with respect to the
               announcement of the adoption of the Rights Agreement.


                                 Page 4 of 6




                                    SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                        OPHTHALMIC IMAGING SYSTEMS

January 2, 1998                          By: /s/ STEVEN R. VERDOONER
                                             ----------------------
                                                 Steven R. Verdooner
                                                 CHIEF EXECUTIVE OFFICER
                                                    AND SECRETARY


                                   Page 5 of 6




                                 EXHIBIT INDEX

EXHIBIT NO.    DESCRIPTION

     1  -   Rights Agreement, dated as of December 31, 1997, between
            Ophthalmic Imaging Systems and American Securities Transfer, Inc.,
            including form of Rights Certificate attached thereto.

     2  -   Press Release dated December 31, 1997 with respect to the
            announcement of the adoption of the Rights Agreement.


                                   Page 6 of 6